A hospital finance director somewhere in England is, right now, staring at a licensing renewal that costs more than a ward's annual staffing budget. That scene, unremarkable and repeated across the service, is the quiet backdrop against which a trust chief executive's public defence of home-grown digital infrastructure lands with unusual force. The claim is straightforward: locally built systems cost a fraction of commercial alternatives and can be shaped precisely around clinical workflow rather than around a vendor's product roadmap. The implications reach considerably further than one trust's IT budget.

Electronic patient record procurement has become one of the most expensive undertakings in NHS history, with several major contracts running into hundreds of millions of pounds. Against that backdrop, a trust that has built its own tools and declined to join the national Federated Data Platform is making an argument that goes beyond thrift. It is asserting that local judgement about clinical utility should carry more weight than compliance with a nationally mandated architecture, and it is doing so at a moment when that argument has real institutional company.

More than a year after NHS England set out an "FDP first" policy and pushed for near-universal adoption, uptake remains stubbornly uneven. A meaningful proportion of trusts, including some of the largest and most digitally advanced, have yet to go live. Leeds Teaching Hospitals concluded through formal assessment that adopting FDP products would mean losing functionality rather than gaining it. Other trusts across Warwickshire, Essex and London held off because they were already building systems of their own. Parliament's Health and Social Care Committee has gone further, calling on ministers to drop Palantir from the platform altogether, citing mistrust and what it termed contested benefits. None of this reads as isolated grumbling. It reads as a pattern of considered institutional resistance to a policy the centre still treats as settled.

What makes the pattern significant is timing. Sir Jim Mackey's accountability drive has reoriented much of NHS leadership culture around financial discipline and provider performance, yet it has said comparatively little about whether trusts should be trusted with genuine digital autonomy or steered towards a single national architecture regardless of local evidence. A chief executive standing up to defend an in-house system is testing which of those instincts actually governs the service. If Mackey's framework rewards demonstrable value for money, a system that costs less and works better ought to be vindicated. If it quietly expects conformity to centrally sanctioned platforms irrespective of local performance, that same chief executive is taking a real risk by speaking publicly.

There is a harder question sitting beneath the cost figures, and it belongs to NHS England rather than to any individual trust. The FDP was pitched as essential infrastructure for an NHS that needs joined-up data to manage waiting lists, discharge planning and, increasingly, clinical AI at scale. That case depended on the platform demonstrably outperforming what trusts could build for themselves. Growing evidence suggests the opposite is at least sometimes true, and NHS England's own officials have struggled to give the select committee a clear account of which benefits are actually attributable to the platform rather than to other digital investment happening in parallel.

None of this settles the argument for or against a nationally federated data layer. There are legitimate reasons why interoperability at scale needs common standards that no single trust can deliver alone, and a landscape of two hundred bespoke systems would create its own fragility. But the response to a trust defending its own technology cannot simply be an appeal to inevitability. If the centre wants adoption rather than resentful compliance, it needs an argument for why standardisation earns its cost premium, made in terms more concrete than strategic necessity. Until that argument arrives, expect more chief executives to say quietly what this one has said out loud, and expect the answer from Whitehall to keep sounding like an instruction rather than a case.